The Proven Decision Tree For A Supplier Change Notice
A buyer-side decision tree for handling an intermediate supplier change notice — what to accept, contest, or reject, and how to log the call.
Orforglipron Intermediate;(S)-Orforglipron Carboxylic Acid Intermediate;GLP-1 Agonist API Intermediate (Indole-Oxadiazole Core)
CAS:2212021-83-3
Chemical Formula:C22H25N3O5
Molecular Weight:411.46
Availability: R&D; Commercialization
⬤ CAS No.2212021-83-3
⬤ Packaging type:
20kg barrel;5kg barrel;1kg bag;500g bag ; Customized Packaging
| Product Name | 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid |
| CAS No. | 2212021-83-3 |
| Chemical Formula | C22H25N3O5 |
| Molecular Weight | 411.46 |
| Related Categories | Orforglipron Intermediate |
| Density | 1.48±0.1 g/cm3(Predicted) |
| Acidity coefficient (pKa) | 4.55±0.30(Predicted) |
| InChIKey | VWANSYGDVGYGTG-ODJFAWIYNA-N |
| Note | This product is specifically used as a chemical synthesis intermediate for orforglipron and other GLP-1 receptor agonist drugs and is not suitable for direct drug preparation or clinical use. |
| Core drug synthesis | Our product is a key intermediate of Orforglipron and is mainly used for: synthesize GLP-1 receptor agonist drugs, targeted treatment of type 2 diabetes and obesity. |
| R&D and extended applications | As a structural template for optimizing the activity and pharmacokinetic properties of GLP-1 analogs. |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
A buyer-side decision tree for handling an intermediate supplier change notice — what to accept, contest, or reject, and how to log the call.
A supplier discontinuation is a deadline, not just bad news. The questions to ask in writing, the last-time-buy calculation, and the files to collect in time.
Rejected batch? What to do in the first hour, how to write the notice, who pays the costs, and the escalation path when a supplier stalls.
Manufacturer and supplier of pharmaceutical APIs and intermediates. Contact us for technical support and sourcing solutions.